Supreme Court asked to restore access to mail-order abortion pill mifepristone

A pharmaceutical company that produces mifepristone asked the Supreme Court on Saturday to lift a lower court's ruling prohibiting health providers from dispensing the abortion pill by mail.In an emergency application filed Saturday, Danco Laboratories argued that Friday's ruling from the 5th U.S. Circuit Court of Appeals "causes immediate confusion and dramatic upheaval for manufacturers, distributors, providers, pharmacies, and patients around the country.""The resulting chaos for patients, providers, pharmacies, and the drug-regulatory system is a quintessential irreparable harm that underscores the need for emergency relief from this Court," lawyers for the company wrote in their filing. In this April 13, 2023, file photo, packages of Mifepristone tablets are displayed at a family planning clinic, in Rockville, Md.Anna Moneymaker/Getty Images, FILEThe lower court's order takes effect immediately and temporarily blocks 2023 Food and Drug Administration guidelines from the Biden administration that had eased access to the pill, citing an ongoing safety review by the Trump administration. The stay is in place as litigation continues.The application comes two years after the justices unanimously rejected a similar legal challenge to mifepristone, concluding that the doctors and anti-abortion groups who sued over the drug did not have standing.In their application on Saturday, lawyers for